Therapeutic application of regeneration-associated cells: a novel

Chronic diseases with comorbidities or associated risk factors may impair the function of regenerative cells and the regenerative microenvironment. Following this consideration, the vasculogenic conditioning culture (VCC) method was developed to boost the regenerative microenvironment to achieve regeneration-associated cells (RACs), which contain vasculogenic endothelial progenitor cells (EPCs) and anti-inflammatory/anti-immunity cells. Preclinical and clinical studies demonstrate that RAC transplantation is a safe and convenient cell population for promoting ischemic tissue recovery based on its strong vasculogenicity and functionality. The outputs of the scientific reports reviewed in the present study shed light on the fact that RAC transplantation is efficient in curing various diseases. Here, we compactly highlight the universal features of RACs and the latest progress in their translation toward clinics.

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow

Human peripheral blood mononuclear cells enriched in endothelial

PDF) Endothelial Progenitor Cells inhibit jaw osteonecrosis in a

Endothelial Progenitor Cells inhibit jaw osteonecrosis in a rat

Cell therapy trials for heart regeneration — lessons learned and

Novel insight into the management of bisphosphonate-related

Schematic representation of the mechanisms underlying the

Characterization of extracellular vesicles. (A–C) Nano tracking

Regeneration-associated cells increased post-QQ culturing. (A) The

Cell therapy trials for heart regeneration — lessons learned and

Cell Regeneration Therapy: Advancements & Limitations (2023)

Rethinking regeneration: empowerment of stem cells by inflammation

Frontiers From Cell Death to Regeneration: Rebuilding After Injury

3 Amazing Benefits of Regenerative Medicine: Bahri Orthopedics

Regenex - Stem Cell Supplement Made of Purest AFA for Cells